読み込み中
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
前日終値
$2.39
+$0.01 · +0.42%
日中の時刻はETです。市場データは遅延する場合があります。
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
日中レンジ
現在 $2.39
52週レンジ
現在 $2.39
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
58
適正価値
センチメント
63
強気
リスク
72
高リスク
モメンタム
22
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
日中レンジ
現在 $2.39
52週レンジ
現在 $2.39
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 601.7万 USD | 52万 USD | 64.4万 USD | 78.7万 USD | 52.2万 USD |
| 売上原価 | 50万 USD | 58.2万 USD | 58.3万 USD | 46.3万 USD | 29.8万 USD |
| 粗利益 | 551.7万 USD | −6.2万 USD | 6.1万 USD | 32.4万 USD | 22.4万 USD |
| 研究開発 | 351.1万 USD | 365.9万 USD | 294.2万 USD | 426.2万 USD | 599万 USD |
| 販売・一般管理 | 2312.7万 USD | 1011.8万 USD | 927.1万 USD | 1064万 USD | 1217.6万 USD |
| 営業費用 | 2663.8万 USD | 1384.1万 USD | 1248.9万 USD | 1584万 USD | 1836.6万 USD |
| 受取利息 | — | — | 25.7万 USD | — | — |
| 支払利息 | 63.5万 USD | 1.7万 USD | — | 83.4万 USD | — |
| 減価償却費と償却費 | 68万 USD | 6万 USD | 16.2万 USD | 25.5万 USD | 31.2万 USD |
| 営業利益 | −2112.1万 USD | −1390.3万 USD | −1242.8万 USD | −1551.6万 USD | −1814.2万 USD |
| 純利益 | −4089万 USD | −1174.2万 USD | −885万 USD | −1407.2万 USD | −1813.2万 USD |
会社概要が更新されました 2026年10月12日.
この株式へのエクスポージャーを報告している上場投資信託です。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
